External Source

David Sallman, Md, Offers Details Regarding The Clinical Investigation Of Cyad-01

2021 2:07
Synopsis
Dr. Sallman, Assistant Member, Department of Malignant Hematology, Moffitt Cancer Center, shares outcomes from the clinical ...

You Might Also Like

David Sallman, MD, elaborates on the first-in-class anti-CD47 antibody magrolimab 1:57
David Sallman, Md, Elaborates On The First-in-class Anti-cd4...
2021
How Researchers Can Actually Influence Policy | FastTrack LIVE Workshop #31
How Researchers Can Actually Influence Policy | Fasttrack Li...
2025
David Sallman, MD & Jeffrey Lancet, MD: Menin inhibition & combo strategies in AML 3:39
David Sallman, Md & Jeffrey Lancet, Md: Menin Inhibition & C...
2025
ASCO22 Leukemia Updates | David Sallman, MD | Moffitt Cancer Center 4:10
Asco22 Leukemia Updates | David Sallman, Md | Moffitt Cancer...
2022
ASH 2024: David Sallman, MD on MRD Evaluation via NGS with CPX-351 in Acute Myeloid Leukemia 2:38
Ash 2024: David Sallman, Md On Mrd Evaluation Via Ngs With C...
2025
Dr. David Sallman at ASCO 2022: Abstract No. 1:10
Dr. David Sallman At Asco 2022: Abstract No.
2022
ASH 2021 - Dr. David Sallman - Abstract 825 1:49
Ash 2021 - Dr. David Sallman - Abstract 825
2022
Safety and efficacy of SX-682 in HMA failure MDS 1:57
Safety And Efficacy Of Sx-682 In Hma Failure Mds
2023
ASH 2021 - Dr. David Sallman - Abstract 246 2:00
Ash 2021 - Dr. David Sallman - Abstract 246
2022
ASH 2024: Drs. David Sallman and Jeff Lancet Discuss Measurable Residual Disease in AML and MDS 4:02
Ash 2024: Drs. David Sallman And Jeff Lancet Discuss Measura...
2024
UnitedHealthcare DOJ Probe + 25% Drug Denials EXPLAINED 5:16
Unitedhealthcare Doj Probe + 25% Drug Denials Explained
2025
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.